Androgen deprivation therapy and the risk of death from prostate cancer among men with favorable or unfavorable intermediate-risk disease

Publisher： Blackwell Publishing

E-ISSN： 1097-0142|121|16|2713-2719

ISSN： 0008-543X

Source： Cancer, Vol.121, Iss.16, 2015-08, pp. : 2713-2719

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Current trends for the use of androgen deprivation therapy in conjunction with radiotherapy for patients with unfavorable intermediate-risk, high-risk, localized, and locally advanced prostate cancer

By Roach Mack

Cancer, Vol. 120, Iss. 11, 2014-06 ,pp. : 1620-1629

Blackwell Publishing

Access to resources Recommend Favorite

Androgen Deprivation Therapy and the Risk of Coronary Heart Disease and Heart Failure in Patients with Prostate Cancer: A Nested Case-Control Study in UK Primary Care

By Martín-Merino Elisa

Drug Safety, Vol. 34, Iss. 11, 2011-11 ,pp. : 1061-1077

Adis International

Access to resources Recommend Favorite

Adverse Effects of Androgen Deprivation Therapy: Defining the Problem and Promoting Health Among Men with Prostate Cancer

By Saylor Philip J. Smith Matthew R.

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 8, Iss. 2, 2010-02 ,pp. : 211-223

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Bisphosphonates to Prevent Osteoporosis in Men Receiving Androgen Deprivation Therapy for Prostate Cancer

By Smith M.R.

Drugs & Aging, Vol. 20, Iss. 3, 2003-01 ,pp. : 175-183

Adis International

Access to resources Recommend Favorite

Management of the side effects of androgen deprivation therapy in men with prostate cancer

By Flaig Thomas W Glodé L Michael

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 16, 2008-11 ,pp. : 2829-2841

Informa Healthcare

Access to resources Recommend Favorite